[1] Lewis D. F. V. “Cytochromes P450-Structure, Function and Mechanism.” Taylor and
Francis Ltd., 79-113 (1996).
[2] Ōmura T., Ishimura Y. and Fujii Y. “Molecular Biology of P450.” Kodansha scientific,
(2003) (in Japanese).
[3] Lamb D. C., Zhao B., Guengerich F. P., Kelly S. L. and Waterman M. R. “Genomics
of Streptomyces cytochrome P450. In Streptomyces Molecular Biology and
Biotechnology” (P. Dyson, Ed.), Caister Academic Press, Norfolk, UK, 233-253 (2011).
[4] Rudolf J. D., Chang C. Y., Ma M. and Shen B. “Cytochromes P450 for natural product
biosynthesis in Streptomyces: sequence, structure, and function.” Nat. Prod. Rep., 34,
1141-1172 (2017).
[5] Hussain H. A. and Ward J. M. “Enhanced heterologous expression of two
Streptomyces griseolus cytochrome P450s and Streptomyces coelicolor ferredoxin
reductase as potentially efficient hydroxylation catalysts.” Appl. Environ. Microbiol., 69,
373–382 (2003).
[6] Matsuoka T., Miyakoshi S., Tanzawa K., Nakahara K., Hosobuchi M. and Serizawa
N. “Purification and characterization of cytochrome P450sca from Streptomyces
carbophilus. ML-236B (compactin) induces P450sca in Streptomyces carbophilus that
hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3hydroxy-3-methylglutaril coenzyme-A reductase.” Eur. J. Biochem., 184, 707–713
(1989).
[7] Sasaki J., Miyazaki A., Saito M., Adachi T., Mizoue K., Hanada K. and Ōmura S.
“Transformation of vitamin D3 to 1α,25-dihydroxyvitamin D3 via 25-hydroxyvitamin D3
using Amycolata sp. strains.” Appl. Microbiol. Biotechnol., 38, 152-157 (1992).
[8] Takeda K., Asou T., Matsuda A., Kimura K., Okamura K., Okamoto R., Sasaki J.,
Adachi T. and Ōmura S. “Application of cyclodextrin to microbial transformation of
vitamin D3 to 25-hydroxyvitamin D3 and 1α,25-dihydroxyvitamin D3.” J. Ferment.
Bioeng., 78, 380-382 (1994).
102
[9] Kinashi H., Mori E., Hatani A. and Nimi O. "Isolation and characterization of linear
plasmids from lankacidin-producing Streptomyces species." J. Antibiot., 47, 1447-1455
(1994).
[10] Mochizuki S, Hiratsu K, Suwa M., Ishii T., Sugino F., Yamada K. and Kinashi H.
“The large linear plasmid pSLA2-L of Streptomyces rochei has an unusually condensed
gene organization for secondary metabolism.” Mol. Microbiol., 48, 1501-1510 (2003).
[11] Arakawa K., Mochizuki S., Yamada K., Noma T. and Kinashi H. “γ-Butyrolactone
autoregulator-receptor system involved in lankacidin and lankamycin production and
morphological differentiation in Streptomyces rochei.” Microbiology, 153, 1817-1827
(2007).
[12] Yamamoto S., He Y., Arakawa K. and Kinashi H. “Gamma-Butyrolactonedependent expression of the SARP gene srrY plays a central role in the regulatory cascade
leading to lankacidin and lankamycin production in Streptomyces rochei.” J. Bacteriol.,
190, 1308–1316 (2008).
[13] Nindita Y., Cao Z., Fauzi A.A., Teshima A., Misaki Y., Muslimin R., Yang Y.,
Shiwa Y., Yoshikawa H., Tagami M., Lezhava A., Ishikawa J., Kuroda M., Sekizuka T.,
Inada K., Kinashi H. and Arakawa K. “The genome sequence of Streptomyces rochei
7434AN4, which carries a linear chromosome and three characteristic linear plasmids.”
Sci. Rep., 9, 10973 (2019)
[14] Senate L. M., Tjatji M. P., Pillay K., Chen W., Zondo N. M., Syed P. R., Mnguni F.
C., Chiliza Z. E., Bamal H. D., Karpoormath R., Khoza T., Mashele S. S., Blackburn J.
M., Yu J., Nelson D. R. and Syed K. “Similarities, variations, and evolution of
cytochrome P450s in Streptomyces versus Mycobacterium.” Sci. Rep., 9, 3962 (2019).
[15] Kieser T., Bibb M. J., Buttner M. J., Chater K. F. and Hopwood D. A. “Practical
Streptomyces Genetics” The John Innes Foundation, Norwich, UK (2000).
[16] Zhang H., Shinkawa H., Ishikawa J., Kinashi H. and Nimi O. “Improvement of
transformation system in Streptomyces using a modified regeneration medium.” J.
Ferment. Bioeng., 83, 217–221 (1997).
103
[17] Sambrook J., Fritsch E. F. and Maniatis T. “Molecular Cloning, A laboratory manual.”
Cold Spring Harbor Laboratory Press, New York, USA (2001).
[18] Suwa M., Sugino H., Sasaoka A., Mori E., Fujii S., Shinkawa H., Nimi O. and
Kinashi H. "Identification of two polyketide synthase gene clusters on the linear plasmid
pSLA2-L in Streptomyces rochei." Gene., 246, 123-131 (2000).
[19] Hopwood D. A., Wright H. M., Bibb M. J. and Cohen S. N. “Genetic recombination
through protoplast fusion in Streptomyces.” Nature, 268, 171–174 (1977).
[20] Sambrook J., Fritsch E. F. and Maniatis T. “Molecular Cloning: A Laboratory
Manual” Cold Spring Harbor Laboratory Press, New York, USA (1989).
[21] Bibb M. J. “Regulation of secondary metabolism in streptomycetes.” Curr. Opin.
Microbiol., 8, 208–215 (2005).
[22] Horinouchi S. and Beppu T. “Hormonal control by A-factor of morphological
development and secondary metabolism in Streptomyces.” Proc. Jpn. Acad. Ser. B, 83,
277–295 (2007).
[23] Takano E. “Gamma-butyrolactones: Streptomyces signalling molecules regulating
antibiotic production and differentiation.” Curr. Opin. Microbiol. 9, 287–294 (2006).
[24] Niu G., Chater K. F., Tian Y., Zhang J. and Tan H. “Specialized metabolites
regulating antibiotic biosynthesis in Streptomyces spp.” FEMS Microbiol. Rev., 40, 554–
573 (2016).
[25] Arakawa K. “Manipulation of metabolic pathway controlled by signaling molecules,
inducers of antibiotic production, for genome mining in Streptomyces spp.” Antonie Van
Leeuwen., 111, 743–751 (2018).
[26] Kong D., Wang X., Nie J. and Niu G. “Regulation of antibiotic production by
signaling molecules in Streptomyces.” Front. Microbiol., 10, 2927 (2019).
[27] Hara O. and Beppu T. “Mutants blocked in streptomycin production in Streptomyces
griseus–the role of A-factor.” J. Antibiot., 35, 349–358 (1982).
104
[28] Kato J., Funa N., Watanabe H., Ohnishi Y. and Horinouchi S. “Biosynthesis of
gamma-butyrolactone autoregulators that switch on secondary metabolism and
morphological development in Streptomyces.” Proc. Natl. Acad. Sci. USA, 104, 2378–
2383 (2007).
[29] Corre C., Song L., O’Rourke S., Chater K. F. and Challis G.L. “2-Alkyl-4hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by
Streptomyces coelicolor genome mining.” Proc. Natl. Acad. Sci. USA, 105, 17510–17515
(2008).
[30] Kitani S., Miyamoto K. T., Takamatsu S., Herawati E., Iguchi H., Nishitomi K.,
Uchida M., Nagamitsu T., Ōmura S., Ikeda, H. and Nihira T. “Avenolide, a Streptomyces
hormone controlling antibiotic production in Streptomyces avermitilis.” Proc. Natl. Acad.
Sci. USA, 108, 16410–16415 (2011).
[31] Arakawa K., Tsuda N., Taniguchi A. and Kinashi H. “The butenolide signaling
molecules SRB1 and SRB2 induce lankacidin and lankamycin production in
Streptomyces rochei.” Chem. Bio. Chem., 13, 1447–1457 (2012).
[32] Rodriguez A. M., Olano C., Méndez C., Hutchinson C. R. and Salas J. A. “A
cytochrome P450-like gene possibly involved in oleandomycin biosynthesis by
Streptomyces antibioticus.” FEMS Microbiol. Lett., 127, 117–120 (1995).
[33] Misaki Y., Yamamoto S., Suzuki T., Iwakuni M., Sasaki H., Takahashi Y., Inada K.,
Kinashi H. and Arakawa K. “SrrB, a pseudo-receptor protein, acts as a negative regulator
for lankacidin and lankamycin production in Streptomyces rochei.” Front. Microbiol., 11,
1089 (2020).
[34] Arakawa K., Kodama K., Tatsuno S., Ide S. and Kinashi H. “Analysis of the loading
and hydroxylation steps in lankamycin biosynthesis in Streptomyces rochei.” Antimicrob.
Agents Chemother., 50, 1946–1952 (2006).
[35] Suzuki T., Mochizuki S., Yamamoto S., Arakawa K. and Kinashi H. “Regulation of
lankamycin biosynthesis in Streptomyces rochei by two SARP genes, srrY and srrZ.”
Biosci. Biotechnol. Biochem., 74, 819–827 (2010).
105
[36] Ishikawa J., Niino Y. and Hotta K. “Construction of pRES18 and pRES19,
Streptomyces-Escherichia coli shuttle vectors carrying multiple cloning sites.” FEMS
Microbiol. Lett., 145, 113–116 (1996).
[37] Arakawa K., Sugino F., Kodama K., Ishii T. and Kinashi H. “Cyclization mechanism
for the synthesis of macrocyclic antibiotic lankacidin in Streptomyces rochei.” Chem.
Biol., 12, 249–256 (2005)
[38] Bourguignon J. J. and Wermuth C.G. “Lactone chemistry. Synthesis of β-substituted,
γ-functionalized butanolides and butenolides and succinaldehydic acids from glyoxylic
Acid.” J. Org. Chem. 46, 4889–4894 (1981).
[39] Feringa B.L., de Lange B. and de Jong J.C. “Synthesis of enantiomerically pure γ(menthyloxy) butenolides and (R)- and (S)-2-methyl-1,4-butanediol.” J. Org. Chem., 54,
2471–2475 (1989).
[40] Ohtani I., Kusumi T., Kashman Y. and Kakisawa H. “High-field FT NMR
application of Mosher’s method. The absolute configurations of marine terpenoids.” J.
Am. Chem. Soc., 113, 4092–4096 (1991).
[41] Yamauchi Y., Nindita Y., Hara K., Umeshiro A., Yabuuchi Y., Suzuki T., Kinashi
H. and Arakawa K. “Quinoprotein dehydrogenase functions at the final oxidation step of
lankacidin biosynthesis in Streptomyces rochei 7434AN4.” J. Biosci. Bioeng., 126, 145–
152 (2018).
[42] Tamura M. and Kochi J. “Coupling of Grignard reagents with organic halides.”
Synthesis, 3, 303–305 (1971).
[43] Arakawa K., Eguchi T. and Kakinuma K. “Specific deuterium labeling of archaeal
36-membered macrocyclic diether lipid.” Bull. Chem. Soc. Jpn., 71, 2419–2426 (1998).
[44] Sakuda S., Higashi A., Tanaka S., Nihira T. and Yamada Y. “Biosynthesis of
virginiae butanolide, a butyrolactone autoregulator from Streptomyces.” J. Am. Chem.
Soc., 114, 663–668 (1992).
106
[45] Niehs S. P., Kumpfmuüller J., Dose B., Little R. F., Ishida K., Florez L. V.,
Kaltenpoth M. and Hertweck C. “Insect-associated bacteria assemble the antifungal
butenolide gladiofungin by non-canonical polyketide chain termination.” Angew. Chem.
Int. Ed. Engl., 59, 23122-23126 (2020).
[46] Nakou I. T., Jenner M., Dashti Y., Romero-Canelón I., Masschelein J.,
Mahenthiralingam E., and Challis G. L. “Genomics-driven discovery of a novel
glutarimide antibiotic from Burkholderia gladioli reveals an unusual polyketide synthase
chain release mechanism.” Angew.Chem. Int. Ed., 59, 23145–23153 (2020).
[47] Ōmura S. “Macrolide Antibiotics: Chemistry, Biology, and Practice.” Academic
Press, New York, USA (2002).
[48] Trefzer A., Salas J. A., and Bechthold A. “Genes and enzymes of deoxy-sugar
biosynthesis.” Nat. Prod. Rep., 16, 283-99 (1999).
[49] Gäumann E, Hütter R, Keller-Schierlein W., Neipp L., Prelog V. and Zähner H.
“Lankamycin und lankacidin.” Helv. Chim. Acta, 43, 601-606 (1960).
[50] Harada S., Higashide E., Fugono T. and Kishi T. “Isolation and structures of T-2636
antibiotics.” Tetrahedron Lett., 10, 2239-2244 (1969).
[51] Ayoub A. T., El-Magd R. M. A., Xiao J., Lewis C. W., Tilli T. M., Arakawa K.,
Nindita Y., Chan G., Sun L., Glover M., Klobukowski M. and Tuszynski J. “Antitumor
activity of lankacidin antibiotics is due to microtubule stabilization via a paclitaxel-like
mechanism.” J. Med. Chem., 59, 9532–9540 (2016).
[52] Ayoub A. T., Elrefaiy M. A. and Arakawa K. “Computational prediction of the mode
of binding of antitumor lankacidin C to tubulin.” ACS Omega., 4, 4461–4471 (2019).
[53] Auerbach T., Mermershtain I., Davidovich C., Bashan A., Belousoff M., Wekselman
I., Zimmerman E., Xiong L., Klepacki D., Arakawa K., Kinashi H., Mankin A. S. and
Yonath A. “The structure of ribosome-lankacidin complex reveals ribosomal sites for
synergistic antibiotics.” Proc. Natl. Acad. Sci. USA, 107, 1983–1988 (2010).
107
[54] Belousoff M. J., Shapira T., Bashan A., Zimmerman E., Rozenberg H., Arakawa K.,
Kinashi H. and Yonath A. “Crystal structure of the synergistic antibiotic pair, lankamycin
and lankacidin, in complex with the large ribosomal subunit.” Proc. Natl. Acad. Sci. USA,
108, 2717–2722 (2011).
[55] Arakawa K., Suzuki T. and Kinashi H. “Gene disruption analysis of two
glycosylation steps in lankamycin biosynthesis in Streptomyces rochei.” Actinomycetol,
22, 35-41 (2008).
[56] Arakawa K. “Genetic and biochemical analysis of the antibiotic biosynthetic gene
clusters on the Streptomyces linear plasmid.” Biosci. Biotechnol. Biochem., 78, 183–189
(2014).
[57] Agematu H., Matsumoto N., Fujii Y., Kabumoto H., Doi S., Machida K., Ishikawa
j. and Arisawa A. “Hydroxylation of testosterone by bacterial cytochromes P450 using
the Escherichia coli expression system.” Biosci. Biotechnol. Biochem., 70, 307-311
(2006).
[58] Teshima A., Hadae N., Tsuda N. and Arakawa K. “Functional analysis of P450
monooxygenase SrrO in the biosynthesis of butenolide-type signaling molecules in
Streptomyces rochei.” Biomolecules, 10, 1237 (2020).
[59] Arakawa K., Cao Z., Suzuki N. and Kinashi H. “Isolation, structural elucidation, and
biosynthesis of 15-norlankamycin derivatives produced by a type-II thioesterase
disruptant of Streptomyces rochei.” Tetrahedron, 67, 5199-5205 (2011).
[60] Andersen J.F. and Hutchinson C.R. “Characterization of Saccharopolyspora
erythraea cytochrome P-450 genes and enzymes, including 6-deoxyerythronolide B
hydroxylase.” J. Bacteriol., 174, 725-735 (1992).
[61] Haydock S. F., Dowson J. A., Dhillon N. Roberts G. A., Cortes J. and Leadlay P. F.
“Cloning and sequence analysis of genes involved in erythromycin biosynthesis in
Saccharopolyspora erythraea: sequence similarities between EryG and a family of Sadenosylmethionine-dependent methyltransferases.” Mol. Gen. Genet., 230, 120-128
(1991).
108
[62] Weber J. M., Leung J.O., Swanson S. J., Idler K. B. and McAlpine J. B. “An
erythromycin derivative produced by targeted gene disruption in Saccharopolyspora
erythraea.” Science, 252, 114-117 (1991).
[63] Guengerich F. P. “Common and uncommon cytochrome P450 reactions related to
metabolism and chemical toxicity.” Chem. Res. Toxicol., 14, 611-650 (2001).
[64] Ortiz de Montellano P. R. “Cytochrome P450: Structure, Mechanism and
Biochemistry, 3rd ed.” Kluwer Academic Press/Plenum, New York, USA (2005).
[65] Liu G., Chater K. F., Chandra G., Niu G. and Tan H. “Molecular regulation of
antibiotic biosynthesis in Streptomyces.” Microbiol. Mol. Biol. Rev., 77, 112–143 (2013).
[66] Martín J. F. and Liras P. “Harnessing microbiota interactions to produce bioactive
metabolites: Communication signals and receptor proteins.” Curr. Opin. Pharmacol., 48,
8–16 (2019).
[67] Thao N. B., Kitani S., Nitta H., Tomioka T. and Nihira T. “Discovering potential
Streptomyces hormone producers by using disruptants of essential biosynthetic genes as
indicator strains.” J. Antibiot., 70, 1004-1008 (2017).
[68] Li S., Chaulagain M. R., Knauff A. R., Podust L. M.,Montgomery J. and Sherman
D. H. “Selective oxidation of carbolide C–H bonds by an engineered macrolide P450
mono-oxygenase.” Proc. Natl. Acad. Sci. USA, 106, 18463-18468 (2009).
109
公表論⽂
(1) Functional analysis of P450 monooxygenase SrrO in the biosynthesis of butanolidetype signaling molecules in Streptomyces rochei
Aiko Teshima, Nozomi Hadae, Naoto Tsuda, and Kenji Arakawa
Biomolecules, 10(9), 1237 (2020).
DOI : 10.3390/biom10091237
(2) Substrate specificity of two cytochrome P450 monooxygenases involved in
lankamycin biosynthesis
Aiko Teshima, Hisashi Kondo, Yu Tanaka, Yosi Nindita, Yuya Misaki, Yuji Konaka,
Yasuhiro Itakura, Tsugumi Tonokawa, Haruyasu Kinashi, and Kenji Arakawa
Bioscience, Biotechnology, and Biochemistry, 85(1), 115-125 (2021).
DOI : 10.1093/bbb/zbaa063
参考論⽂
(1) The genome sequence of Streptomyces rochei 7434AN4, which carries a linear
chromosome and three characteristic linear plasmids.
Yosi Nindita, Zhisheng Cao, Amirudin Akhmad Fauzi, Aiko Teshima, Yuya
Misaki, Rukman Muslimin, Yingjie Yang, Yuh Shiwa, Hirofumi Yoshikawa,
Michihira Tagami, Alexander Lezhava, Jun Ishikawa, Makoto Kuroda, Tsuyoshi
Sekizuka, Kuninobu Inada, Haruyasu Kinashi, and Kenji Arakawa
Scientific Reports, 9, 10973 (2019).
DOI : 10.1038/s41598-019-47406-y
...
論文の公開元へ
